Availability: | |
---|---|
Emergency & Critical Care:
Shock (Septic/Anaphylactic) – Reduces inflammation and stabilizes blood pressure.
Cerebral Edema – Decreases brain swelling (e.g., post-stroke, tumor-related).
Severe Allergic Reactions – Rapid-acting for asthma attacks or angioedema.
Chemotherapy Support:
Prevents nausea/vomiting induced by chemo/radiation.
Reduces inflammation from tumor compression.
Eye Drops/Injections:
Treats uveitis, allergic conjunctivitis, and post-eye surgery inflammation.
Example: Dexamethasone Sodium Phosphate Ophthalmic Solution (0.1%).
Nebulized Solutions:
Used for croup (laryngotracheobronchitis) in children.
Combined with bronchodilators for severe asthma.
Ear Drops: Otitis externa/interna.
Intra-Articular Injections: Joint inflammation (e.g., rheumatoid arthritis).
Livestock/Pets:
Treats inflammation, autoimmune disorders, and allergic reactions.
Example: Canine atopic dermatitis, equine asthma.
Cell Culture:
Suppresses immune responses in vitro (e.g., lymphocyte studies).
Animal Studies:
Induces hyperglycemia or immunosuppression in lab models.
Handling and Storage
Handling: Approved respirator. Chemical safety goggles. Rubber gloves. Use only in
chemical fume hood. Safety shower and eye-bath. Do not get in eyes, on skin, on clothing.
Avoid inhalation. Avoid prolonged or repeated exposure. Wash thoroughly after handling.
Pregnant women should avoid inhaling the product and not let it come in contact with the
skin.
Storage: Protect from light. Keep in a well-closed container at NMT 25℃
CAS No. | 2392-39-4 |
Synonym | Decadronphosphate Dexamethasone 21-phosphate disodium salt Dexamethasone 21-(disodium phosphate) |
EINECS No. | 200-021-7 |
Molecular Formula | C22H28FNa2O8P |
Molecular Weight | 516.4 |
Appearance | White or almost white crystalline powder |
Assay (%) | 97~102 |
PH | 7.5~10.5 |
Melting Point | 233~235 |
Solubility | Very hygroscopic,freely soluble in water,slightly soluble in alcohol,practically insoluble in ether and in methylene chloride.It shows polymorphism. |